PDCD1 and neoplasm: The differences in PD-L1 expression among gynaecologic CCCs may be attributed to the varying tumour microenvironments that have distinctive immune milieus and ought to be taken into consideration in future studies of PD-1/PD-L1 inhibitors as they warrant further investigation.